METiS TechBio
News,AI,Enterprise,China,Biotech / MedTech
METiS TechBio signs $1.1B AI drug-delivery deal with Eli Lilly
METiS TechBio and Eli Lilly will develop tissue-targeted RNA delivery systems in a collaboration carrying up to about $1.1 billion in milestones.
October 20, 2026
METiS TechBio signs $1.1B AI drug-delivery deal with Eli Lilly
October 20, 2026
Tenstorrent raises $1.5B Series E at $6.2B valuation
October 20, 2026
METiS TechBio signs $1.1B AI drug-delivery deal with Eli Lilly
October 20, 2026
Tenstorrent raises $1.5B Series E at $6.2B valuation
October 20, 2026




